Fundraising Fox
Vedana Therapeutics, Inc.
2 known investors
Find your way into Vedana Therapeutics, Inc.
Sign up to see every warm intro you have to Vedana Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vedana Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies. The company focuses on the neurological and pharmaceutical sectors to serve the global migraine patient population.
Investors · 2
Canaan Partnerslisted by Canaan PartnersStamford · $500K – $20M
How we know: Canaan Partners's portfolio page · a partner's Signal profile · Not right? Tell us
Westlake Village BioPartnerslisted by Westlake Village BioPartnersLos Angeles · $100K – $5M
How we know: Westlake Village BioPartners's portfolio page · a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Vedana Therapeutics, Inc. do?
- Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies. The company focuses on the neurological and pharmaceutical sectors to serve the global migraine patient population.
- Who are Vedana Therapeutics, Inc.'s investors?
- Vedana Therapeutics, Inc.'s investors include Canaan Partners, Westlake Village BioPartners.